Comparative efficacy and safety of oral P2Y12 inhibitors after non-ST-elevation acute coronary syndromes: a network meta-analysis
Haralambos Karvounis,
George Giannakoulas,
George Kassimis,
Ioannis Doundoulakis,
Stefanos Zafeiropoulos,
Ioannis T Farmakis,
Areti Pagiantza,
Efstratios Karagiannidis,
Dimitrios V Moysidis,
Nikolaos Stalikas,
Lampros K Michalis
Affiliations
Haralambos Karvounis
First Department of Cardiology, University General Hospital of Thessaloniki AHEPA, Thessaloniki, Greece
George Giannakoulas
First Department of Cardiology, University General Hospital of Thessaloniki AHEPA, Thessaloniki, Greece
George Kassimis
32nd Department of Cardiology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece
Ioannis Doundoulakis
Cardiology, University General Hospital of Thessaloniki AHEPA, Thessaloniki, Greece
Stefanos Zafeiropoulos
Northwell Health Feinstein Institutes for Medical Research, Manhasset, New York, USA
Ioannis T Farmakis
Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
Areti Pagiantza
Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
Efstratios Karagiannidis
Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
Dimitrios V Moysidis
Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
Nikolaos Stalikas
Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
Lampros K Michalis
Second Department of Cardiology, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, Ioannina, Greece
